1)松本誉之.潰瘍性大腸炎外科治療指針改訂.厚生労働科学研究費補助金難治性疾患克服研究事業「難治性炎症性腸管障害に関する調査研究」.平成22年度総括・分担報告書.pp 59-67, 2011
2)Sands BE, Tremaine WJ, Sandborn WJ, et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis : a pilot study. Inflamm Bowel Dis 7 : 83-88, 2001
3)Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353 : 2462-2476, 2005
4)Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330 : 1841-1845, 1994
5)Naganuma M, Ichikawa H, Inoue N, et al. Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients. J Gastroenterol 45 : 936-943, 2010
6)Maser EA, Deconda D, Lichtiger S, et al. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Clin Gastroenterol Hepatol 6 : 1112-1116, 2008
7)Leblanc S, Allez M, Seksik P, et al. Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol 106 : 771-777, 2011
8)Laharie D, Bourreille A, Branche J, et al. Cyclosporine versus infliximab in severe acute ulcerative colitis refractory to intravenous steroids : a randomized trial. Abstract in Digestive Disease Week 2011
9)Kornbluth A, Sachar DB ; Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults : American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 105 : 501-523, 2010
10)Travis SP, Stange EF, Lémann M, et al. European evidence-based Consensus on the management of ulcerative colitis : Current management. J Crohns Colitis 2 : 24-62, 2008
11)Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 60 : 571-607, 2011
12)Reinisch W, Sandborn WJ, Rutgeerts P, et al. Long-term infliximab maintenance therapy for ulcerative colitis : The ACT-1 and -2 extension studies. Inflamm Bowel Dis, in press
13)Lawson MM, Thomas AG, Akobeng AK. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Cochrane Database of Syst Rev 2006, Issue 3. Art. No. : CD005112. DOI : 10.1002/14651858.CD005112.pub2